BioLineRx Ltd.
BLRX
$3.28
-$0.06-1.80%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -977.00K | -3.94M | 5.13M | -3.19M | -5.82M |
| Total Depreciation and Amortization | 119.00K | 176.00K | 165.00K | 1.78M | 840.00K |
| Total Amortization of Deferred Charges | 0.00 | 0.00 | 702.00K | 742.00K | 0.00 |
| Total Other Non-Cash Items | -1.07M | 1.72M | -8.07M | -7.53M | -1.41M |
| Change in Net Operating Assets | -177.00K | 1.87M | -513.00K | -410.00K | -3.43M |
| Cash from Operations | -2.11M | -177.00K | -2.59M | -8.61M | -9.83M |
| Capital Expenditure | -- | -- | -- | 6.00K | 0.00 |
| Sale of Property, Plant, and Equipment | -11.00K | 11.00K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 3.68M | -3.72M | -8.18M | 11.15M | 10.18M |
| Cash from Investing | 3.67M | -3.70M | -8.18M | 11.16M | 10.18M |
| Total Debt Issued | -- | -- | -- | 0.00 | 0.00 |
| Total Debt Repaid | -1.26M | -1.26M | -1.25M | -12.10M | -1.04M |
| Issuance of Common Stock | 340.00K | 2.86M | 10.70M | 10.99M | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -180.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -916.00K | 1.60M | 9.45M | -1.11M | -1.22M |
| Foreign Exchange rate Adjustments | 74.00K | 432.00K | -82.00K | 162.00K | 81.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 725.00K | -1.85M | -1.40M | 1.60M | -787.00K |